Fernando Gómez Muñoz
New trial — Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases
New trial
41/100
Opportunity
Commercial fit6/25
Clinical timing13/20
Biomarker need5/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5
New unknown trial NCT07406126 posted by Fernando Gómez Muñoz: "Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases". New trial on a unknown not yet recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 208 days ago.
ConfidenceHigh · 87%